🚀 Ind-Swift Laboratories | 15-Year Breakout Signals a Structural Trend Change

$INDSWFTLAB 📊 Technical Analysis 🟢 Elliott Wave Structure The prolonged multi-year consolidation appears to have completed a large corrective cycle. The current breakout suggests the stock is entering a powerful Primary Wave 3, which is typically the strongest and longest phase in Elliott Wave theory. This structural shift significantly improves the long-term technical outlook. 🟢 MACD Momentum The MACD has generated a strong bullish crossover with expanding positive momentum, confirming that buyers are firmly in control. The absence of any meaningful bearish divergence further strengthens the probability of trend continuation. 🟢 AVWAP Confirmation The stock has decisively moved above the Anchored VWAP, indicating that institutional participants are now holding profitable positions. The AVWAP is expected to act as dynamic support, increasing the likelihood of sustained upward momentum. 💼 Fundamental Strength Ind-Swift Laboratories is supported by improving business fundamentals: Improving profitability with better operational efficiency. Healthy return ratios supported by disciplined capital allocation. Presence in the pharmaceutical and API manufacturing segment, benefiting from long-term healthcare demand. Focus on product expansion and export opportunities supporting future earnings growth. Strengthening balance sheet and improving financial performance. 🎯 Key Levels to Watch Major Breakout Zone: ₹150–₹155 (should now act as strong long-term support) Potential Upside: ₹280–₹300 over the medium term if momentum and earnings continue to improve. A successful retest of the ₹150–₹155 zone followed by renewed buying would further validate this historic breakout and reinforce the bullish structure.